Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Berkley Capital Management Ltd. Insider Profile
4 Followers
Berkley Capital Management Ltd., Ten Percent Owner at Mirati Therapeutics, holds 2.98M shares in Mirati Therapeutics (Ticker: MRTX).
Berkley Capital Management Ltd. Mirati Therapeutics (MRTX)Ten Percent Owner
Mirati Therapeutics (MRTX)
Ten Percent Owner
Not Ranked
Berkley Capital Management Ltd. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Berkley Capital Management Ltd. does not currently own shares as a corporate insider.
A breakdown of Berkley Capital Management Ltd.'s holdings
Insider Roles
Berkley Capital Management Ltd. does not currently hold a role as a corporate insider.
Roles that Berkley Capital Management Ltd. holds in companies
Most Profitable Insider Trade
Stock:
Mirati Therapeutics
(MRTX)
(MRTX)
Rating:Informative Buy
Date:Feb 02, 2015 - Feb 02, 2016
Return:-0.10%
The most profitable trade made by Berkley Capital Management Ltd.
Berkley Capital Management Ltd.'s Trading History
List of latest transactions for each holding click on a transaction to see Berkley Capital Management Ltd.'s performance on stock
You May Also Like
Berkley Capital Management Ltd. insider profile FAQ
What is the percentage of profitable transactions made by Berkley Capital Management Ltd.?
The percentage of profitable transactions made by Berkley Capital Management Ltd. is ―.
What is the average return per transaction made by Berkley Capital Management Ltd.?
The average return per transaction made by Berkley Capital Management Ltd. is ―.
What stocks does Berkley Capital Management Ltd. hold?
Berkley Capital Management Ltd. holds: MRTX stocks.
What was Berkley Capital Management Ltd.’s latest transaction?
Berkley Capital Management Ltd. latest transaction was an Uninformative Sell of ―.
What was Berkley Capital Management Ltd.'s most profitable transaction?
Berkley Capital Management Ltd.’s most profitable transaction was an Informative Buy of MRTX stock on February 2, 2015. The return on the trade was -0.10%.
What is Berkley Capital Management Ltd.'s role in Mirati Therapeutics?
Berkley Capital Management Ltd.'s role in Mirati Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.